Disease vs Normal Comparative Spatial Metabolomics Service

Revealing Spatially Localized Metabolic Alterations in Disease

Disease-associated metabolic alterations are often highly localized within tissues and cannot be fully captured by bulk metabolomics.

Our Disease vs Normal Comparative Spatial Metabolomics service leverages mass spectrometry imaging (MSI) to enable direct, spatially resolved comparison of metabolite distributions between diseased and matched normal tissues. This MSI-based approach preserves native tissue morphology while precisely mapping region-specific metabolic dysregulation associated with disease pathology.

Submit Your Request Now

Submit Your Request Now

×
Metabolic differences between normal and diseased tissues
  • What is
  • Workflow
  • Deliverables
  • Applications
  • Why choose
  • FAQs
  • Sample preparation

What Is Disease vs Normal Comparative Spatial Metabolomics?

This service integrates mass spectrometry imaging (MSI) with comparative statistical analysis to visualize and quantify metabolic differences between disease and control tissues within intact tissue sections.

By retaining spatial information, this approach allows:

  • Region-of-interest (ROI)–based metabolic comparisons
  • Identification of disease-specific metabolic hotspots
  • Correlation of metabolic alterations with histopathology

Both untargeted discovery and targeted metabolite panels can be applied depending on study goals.

Workflow

disease vs normal comparative spatial metabolomics workflow

Deliverables

Upon completion of your comparative spatial metabolomics project, you will receive a comprehensive data package and detailed reporting. Our standard deliverables include:

  • Project Report: Full documentation of experimental design, methodology, and a summary of key comparative findings between disease and normal states.
  • High-Resolution Spatial Maps: Publication-ready ion heatmaps overlaid on tissue histology to visualize biomarker distribution.
  • Comparative Statistical Analysis: Data highlighting significant metabolic differences, including PCA, PLS-DA, spatial segmentation, and volcano plots.
  • Metabolite Identification: A curated list of differentially expressed metabolites annotated using standard databases.
  • Raw & Processed Data: Secure transfer of all raw mass spectrometry imaging files and processed data matrices for your archives.
  • Expert Consultation: A one-on-one review session with our team to interpret your results and discuss potential next steps.

Applications

  • Tumor vs adjacent normal tissue comparison
  • Neurodegenerative and neurological disease studies
  • Inflammatory and autoimmune disease research
  • Metabolic biomarker discovery
  • Drug response and resistance assessment
  • Preclinical disease model validation

Why Choose Us?

  • Rigorous Statistical Validation We apply advanced comparative statistical analysis (e.g., Volcano Plots, PCA) to identify and quantify metabolic differences that are statistically significant between disease and control groups.
  • Preserved Tissue Architecture Our approach enables the correlation of metabolic alterations directly with histopathology, allowing you to see exactly where dysregulation occurs within the tissue architecture.
  • Flexible Discovery Options Whether you need hypothesis-free exploration to find novel biomarkers or focused analysis on specific pathways, we offer both untargeted discovery and targeted metabolite panels tailored to your specific study goals.
  • Comprehensive Lab Reports: Receive detailed, publication-ready documentation that translates complex spatial data into clear, actionable biological insights.
  • 3–4 Week Turnaround Time: Keep your research on schedule with our reliable and predictable turnaround time, from sample receipt to final data delivery.

FAQs

What spatial scale does this service cover?

This service primarily operates at the tissue and sub-tissue (regional) level. Depending on instrument settings, metabolite distributions can be resolved down to cellular or near-cellular resolution, but interpretation is typically ROI-based rather than single-cell quantitative.

Can disease and normal samples be analyzed on different slides?

Yes, but matched processing and acquisition conditions are strongly recommended to minimize batch effects. Ideally, disease and normal tissues should be processed in parallel.

Is this an absolute quantification service?

By default, this service provides relative or semi-quantitative comparisons between disease and normal tissues.

Absolute quantification may be possible for selected metabolites using internal standards, but it requires additional experimental design and validation.

Learn about other Q&A.

Sample Submission Notes

Sample Type

  • Fresh frozen tissue sections (preferred)
  • Animal or human-derived tissues
  • Solid organs and tumor tissues

Tissue Preparation

  • Snap-frozen immediately after collection
  • Avoid formalin fixation or paraffin embedding
  • Embed in CMC or Gelatin. Avoid OCT whenever possible, as PEG polymers cause severe ion suppression and spectral interference.

Sectioning Requirements

  • Recommended thickness: 8–12 μm
  • Mounted on ITO-coated or conductive slides
  • Consecutive sections are recommended for histology

Storage & Shipping

  • Store sections at –80 °C
  • Ship on dry ice
  • Minimize freeze–thaw cycles

Contact us for pre-project consultation to optimize your sample preparation protocol.

* For Research Use Only. Not for use in diagnostic procedures.
Our customer service representatives are available 24 hours a day, 7 days a week. Inquiry

From Our Clients

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.

* Email
Phone
* Service & Products of Interest
Services Required and Project Description

Great Minds Choose Creative Proteomics